RACHAEL FARIS: Open Payments
NPI 1881475309 · POWELL, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,059 in 69 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $297 · 2025 $1,059
Food & beverage: $1,059
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $547 |
| Otsuka America Pharmaceutical, Inc. | 9 | $152 |
| Axsome Therapeutics, Inc. | 4 | $64 |
| Janssen Pharmaceuticals, Inc | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $41 |
| Bausch Health US, LLC | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Neos Therapeutics, LP | 1 | $24 |
| Alkermes, Inc. | 1 | $21 |
Products named: VRAYLAR, REXULTI, Auvelity, SPRAVATO, Qelbree, APLENZIN, Jornay PM, Adzenys XR-ODT.
Industry payments across OH — which companies pay providers there.
